Naproxen Ab

Naproxen, the active ingredient in Naproxen Ab, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain, inflammation, arthritis and dysmenorrhea in adult patients. GNH USA supplies Naproxen Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces pain and inflammation across several musculoskeletal and gynecologic conditions.

Pain: provides relief from mild to moderate acute pain such as headache or dental pain. Inflammation: reduces swelling associated with soft‑tissue injuries. Arthritis: alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis. Dysmenorrhea: eases menstrual cramps and related discomfort.

Naproxen may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Gastrointestinal discomfort such as nausea, dyspepsia or abdominal pain. - Headache or dizziness. - Mild skin rash or itching. - Elevated blood pressure. - Fluid retention or peripheral edema.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe liver enzyme elevation or hepatitis. - Renal impairment or acute kidney injury. - Cardiovascular events such as myocardial infarction or stroke. - Severe hypersensitivity reactions including anaphylaxis.

Before using Naproxen, consider the following safety measures.

Cardiovascular risk: avoid use in patients with established heart disease or high thrombotic risk. Gastrointestinal history: assess for prior ulcers, bleeding or chronic NSAID use. Renal function: monitor kidney function in patients with existing renal impairment. Concomitant drugs: review use of anticoagulants, other NSAIDs, or corticosteroids. Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Naproxen can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose aspirin: heightened bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible reduction in renal function. - Lithium: NSAIDs may raise lithium serum levels. - Methotrexate: decreased clearance leading to toxicity.